The Patent Finder

Resistentia Pharmaceuticals AB

Also on record
Records under this name other than patents Resistentia Pharmaceuticals AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Resistentia Pharmaceuticals AB

PatentTitleStatus Expires Confidence
US 6,913,749Immunogenic polypeptides for inducing anti-self IgE responses
Formerly held
Lapsed on the fee record
Ended Jul 5, 2013 · From the USPTO record
Lapsed on the fee recordEnded Jul 5, 2013From the USPTO record
US 7,459,158Immunogenic polypeptides for inducing anti-self IgE responses
Formerly held
Lapsed on the fee record
Ended Dec 2, 2012 · From the USPTO record
Lapsed on the fee recordEnded Dec 2, 2012From the USPTO record
US 7,361,742Methods and materials for treating inflammatory conditions
Formerly held
Lapsed on the fee record
Ended Apr 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Apr 22, 2012From the USPTO record
US 7,232,898Chimeric IgE polypeptides and host cells
Formerly held
Lapsed on the fee record
Ended Jun 19, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2011From the USPTO record
US 5,653,980Vaccine comprising part of constant region of IgE for treatment of IgE-mediated allergic reactions
Formerly held
Term ended
Term ended no later than Aug 5, 2017 · Low confidence
Term endedTerm ended no later than Aug 5, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited